Concepedia

Peter Dynoodt

PD

Statistics

Publications

6

Citations

424

H-Index

6

Active since

2012

Affiliations

University College Dublin(Current)

OncoMark (Ireland)

KU Leuven

Ghent University Hospital

Royal College of Surgeons in Ireland

Peter Dynoodt is an author at University College Dublin specializing in molecular oncology, oncology, and medicine.

ORCID

Publications per year

2012–2020

6

Publications

6

Identification of miR-145 as a Key Regulator of the Pigmentary Process

Peter Dynoodt, Pieter Mestdagh, Gert Van Peer et al. · Journal of Investigative Dermatology · 2012 · 119 citations · Full text

, , +13

Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma

Jasper Wouters, Miguel Vizoso, Anna Martínez‐Cardús et al. · BMC Medicine · 2017 · 99 citations · Full text

, , +17

miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells

Peter Dynoodt, Reinhart Speeckaert, Olivier De Wever et al. · International Journal of Oncology · 2013 · 80 citations · Full text

, , +16

Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanoma

Cristiano Guttà, Arman Rahman, Claudia Aura et al. · Cell Death and Disease · 2020 · 57 citations · Full text

, , +17

Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer

Linda Zuurbier, Arman Rahman, Martijn Cordes et al. · Oncotarget · 2017 · 52 citations · Full text

, , +16

1–5 of 6